Novel Biologics in Psoriasis—Safety Considerations : vimarsana.com

Novel Biologics in Psoriasis—Safety Considerations

This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.

Related Keywords

France , French , Jennifer Soung , French National Health Data System , Event Reporting System , Psoriasis Longitudinal Assessment Registry , Risk Evalua , Mitigation Strategy , French National Health Data , Longitudinal Assessment ,

© 2024 Vimarsana